Curaleaf Holdings (CURLF) Profit After Tax Growth (3y) (2022 - 2026)
Curaleaf Holdings (CURLF) Profit After Tax Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 14.01% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.37% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn | 29.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.42% |
| Mar 31, 2026 | 53.12% |
| Dec 31, 2025 | 36.21% |
| Sep 30, 2025 | -9.61% |
| Jun 30, 2025 | -43.13% |
| Mar 31, 2025 | -83.13% |
| Dec 31, 2024 | 3.82% |
| Sep 30, 2024 | 7.96% |
| Jun 30, 2024 | -80.31% |
| Mar 31, 2024 | -76.31% |
| Dec 31, 2023 | -1,060.35% |
| Sep 30, 2023 | -96.55% |
| Jun 30, 2023 | -231.01% |
| Mar 31, 2023 | -41.61% |
| Dec 31, 2022 | -113.10% |
| Sep 30, 2022 | -77.29% |